The board (the "Board") of directors (the "Director") of Frontage Holdings Corporation announces that Dr. Zhihe Li has retired from his Senior Vice President role at Frontage Laboratories Inc. and due to change in work arrangements and has been redesignated from an executive Director to a non-executive Director of the Company with effect from July 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 HKD | -2.91% | -2.91% | -56.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.90% | 267M | |
+39.87% | 55.66B | |
-8.40% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.32% | 26.29B | |
-16.56% | 20.25B | |
+30.40% | 12.76B | |
+27.17% | 12.18B | |
-1.21% | 12.12B |
- Stock Market
- Equities
- 1521 Stock
- News Frontage Holdings Corporation
- Frontage Holdings Corporation Announces Redesignation of A Director